TG Therapeutics
TGTX
TGTX
247 hedge funds and large institutions have $5.19B invested in TG Therapeutics in 2020 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 79 increasing their positions, 57 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% more funds holding
Funds holding: 181 → 247 (+66)
28% more call options, than puts
Call options by funds: $138M | Put options by funds: $107M
3.27% more ownership
Funds ownership: 69.24% → 72.51% (+3.3%)
Holders
247
Holding in Top 10
10
Calls
$138M
Puts
$107M
Top Buyers
| 1 | +$201M | |
| 2 | +$181M | |
| 3 | +$83.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$70.2M |
| 5 |
Alkeon Capital Management
New York
|
+$67.8M |
Top Sellers
| 1 | -$61.9M | |
| 2 | -$46.8M | |
| 3 | -$42.8M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$29M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$25.6M |